- ￥300
- Solarbio
- 北京
- IS0130
- 2025年07月23日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 保质期：
Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 英文名：
Scopolamine hydrobromide
- 库存：
现询
- 供应商：
北京索莱宝科技有限公司
- CAS号：
114-49-8
- 规格：
20mg
| 基本信息 | |
| CAS | No.114-49-8 |
| 中文名称 | HBR东莨菪碱 |
| 英文名称 | Scopolamine hydrobromide |
| 别名 | Hyoscine hydrobromide;Scopine (-)tropate hydrobromide;Scopine tropate hydrobromide |
| 分子式 | C17H22BrNO4 |
| 分子量 | 384.26 |
| 溶解性 | Soluble in Water/DMSO |
| 纯度 | HPLC≥98% |
| 外观(性状) | White to off-white Solid |
| 储存条件 | Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year |
| EC | EINECS 204-050-6 |
| MDL | MFCD00012647 |
| SMILES | CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4.Br |
| InChIKey | WTGQALLALWYDJH-WYHSTMEOSA-N |
| InChI | InChI=1S/C17H21NO4.BrH/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10;/h2-6，11-16，19H，7-9H2，1H3;1H/t11 ，12-，13-，14+，15-，16+;/m1./s1 |
| PubChem CID | 6603108 |
| 靶点 | mAChR |
| 通路 | Neuronal Signaling;GPCR & G Protein |
| 背景说明 | Scopolamine hydrobromide是一种竞争性的毒蕈碱型乙酰胆碱受体拮抗剂。 |
| 生物活性 | Scopolamine hydrobromide is a high affinity (nM) muscarinic antagonist. 5-HT3 receptor-responses are reversibly inhibited by Scopolamine with an IC50 of 2.09 μM.[1-3] |
| In Vitro | Application of Scopolamine to oocytes expressing 5-HT3 receptors does not elicit a response when applied alone， but causes a concentration-dependent inhibition of the response during a co-application of 2 μM 5-HT. The pIC50 value for Scopolamine is 5.68±0.05 (IC50=2.09 μM， n=6) with a Hill Slope of 1.06 ± 0.05. This gave a Kb of 3.23 μM. The same concentration-dependent effect is also seen when Scopolamine is applied during the 5-HT application. To further test for a competitive binding at the 5-HT3 receptor， the competition of unlabelled Scopolamine is measured with [3H]granisetron， an established high-affinity competitive antagonist at these receptors. Scopolamine displays concentration-dependent competition with 0.6 nM [3H]granisetron (~Kd)， yielding an average pKi of 5.17±0.24 (Ki=6.76 μM， n=3)[1]. |
| 细胞实验 | In the histopathology study， there is no significant change in the histology of the brain. However， it is observed that there is a reduction in density of cells in the hippocampus of the control mice pretreated with Scopolamine who received only distilled water[2]. Scopolamine administration alone significantly increases the activity of Acetylcholinesterase enzyme (AchE) (7.98±0.065; P<0.001) when compared to the normal group (3.06±0.296). The animals treated with Scopolamine report a significant increase (34.61±4.85; P<0.01) in levels of malondialdehyde (MDA) as compared to the normal group (12.82±2.86). The Scopolamine-treated group shows significant decrease in reduced glutathione (GSH) level (P<0.001; 0.1504±0.03) as compared to the normal group (0.3906±0.02). The Scopolamine-treated rats show a significant increase in the concentration ofβ amyloid (Aβ1-42) (P<0.001; 146.2±1.74) as compared to the normal group (43.21±3.46)[3]. |
| 动物实验 | Healthy male Wistar rats (12 months old) weighing 180–200 g are used in this study. Rats are divided into five groups (n=6/group); Group I-normal control， Group II-disease control (Scopolamine hydrobromide 3 mg/kg， i.p.)， Group III-Scopolamine+Quercetin (25 mg/kg， p.o.)， Group IV-standard treatment (Scopolamine+Donepezil hydrochloride 3 mg/kg， p.o.)， and Group V-Scopolamine+Quercetin (25 mg/kg， p.o.)+Donepezil (3 mg/kg， p.o.). Group III， IV， and V rats are dosed every 24 h interval with respective drugs for 14 consecutive days. The acquisition trail for Morris water maze， elevated plus maze， and passive avoidance paradigm is carried out on the 14th day， and Scopolamine (3 mg/kg， i.p.) is administered on the 14th day after the acquisition trail to all groups except normal control group， which provoke the cognitive impairment in rats. Retention of memory is tested on the 15th day， and on the same day， rats are sacrificed and brain tissues are isolated to estimate acetylcholinesterase enzyme (AchE) and brain oxidative stress markers such as lipid peroxidase (LPO)， glutathione (GSH) (reduced). ELISA kit is used to estimate β amyloid (Aβ1-42) level. The hippocampus of rat brains is dissected out and studied for histopathological changes.[3] |
| 激酶实验 | Saturation binding (8 point) curves are measured by incubating either crude extracts of HEK 293 cells stably expressing 5-HT3 receptors， or Guinea pig membrane preparations， in 0.5 mL incubations containing 10 mM HEPES buffer (pH 7.4) and 0.1-1 nM [3H]granisetron or 1-10 nM [3H]N-methylScopolamine. Competition binding (10 point) is determined by incubating the same receptors preparations in 0.5 mL HEPES buffer containing either 0.6 nM [3H]granisetron or 0.6 nM [3H]N-methylScopolamine， and differing concentrations of competing ligands. Non-specific binding is determined with 1 mM quipazine or 10 μM Scopolamine respectively. Incubations are terminated by filtration onto Whatman GF/B filters wetted with HEPES buffer+0.3% polyethyleneimine， followed by two rapid washes with ice-cold HEPES buffer. Protein concentration is calculated using a Lowry protein assay with bovine serum albumin standards. Radioactivity is measured using a Tri-Carb 2100 TR scintillation counter[1]. |
| 数据来源文献 | [1]. Lochner M， et al. The muscarinic antagonists Scopolamine and atropine are competitive antagonists at 5-HT3 receptors. Neuropharmacology. 2016 Sep;108:220-8. [2]. O ET， et al. COGNITIVE-ENHANCING PROPERTIES OF MORINDA LUCIDA (RUBIACEAE) AND PELTOPHORUM PTEROCARPUM (FABACEAE) IN SCOPOLAMINE-INDUCED AMNESIC MICE. Afr J Tradit Complement Altern Med. 2017 Mar 1;14(3):136-141. [3]. Pattanashetti LA， et al. Evaluation of neuroprotective effect of Quercetin with Donepezil in Scopolamine-induced amnesia in rats. Indian J Pharmacol. 2017 Jan-Feb;49(1):60-64. |
| 单位 | 瓶 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
，如用药物（利血平）使儿茶酚胺（包括多巴胺）耗竭，则动物会出现类似震颤麻痹的症状；如进一步给予左旋多巴（L-dopa,多巴胺之前体，能通过血脑屏障进入中枢神经系统）治疗，使体内多巴胺合成增加，则症状好转。由此说明，中脑黑质的多巴胺能神经元功能被破坏，是震颤麻痹的主要原因。 图10-38 黑质纹状体环路示意图 1：多巴胺能神经元 2：碱能神经元3：γ-氨基丁酸能神经元 4：纹状体5：黑质致密部6：黑质网状部 早已知道，震颤麻痹患者能用M型胆碱能受体阻断剂（东莨菪碱、安坦
基底神经节包括尾核、壳核、苍白球、丘脑底核、黑质和红核。尾核、壳核和苍白球统称为纹状体。纹状体具有控制肌肉运动的功能，并与丘脑、下丘脑联合成为本能反射的调节中枢，例如完成行走等本能反射活动。 在清醒猴，记录苍白球单个神经元的放电活动时观察到，当肢体进行随意运动时神经元的放电发生明确的变化，说明基底神经节与随意运动活动有关。电刺激纹状体的动物实验中观察到，单纯刺激纹状体并不能引起运动效应；但如在刺激大脑皮层运动区的同时，再刺激纹状体，则皮层运动区发出
STM：傅阳心、侯玉柱等发现放疗与免疫治疗的交汇点，兵家必争之地竟是这群细胞
背景介绍 近期，癌症神经科学以及神经营养配体促进肿瘤恶性进展的相关研究越来越多，也逐渐成为领域内的热点之一。其中，一种神经营养因子 —— Artemin (ARTN)，被发现能够促进肿瘤进展，而 ARTN 主要是由肿瘤诱导产生的 CD45−Ter119+CD71+ 红系祖细胞分泌的，CD45−Ter119+CD71+ 细胞又被称为「Ter 细胞」，为晚期实体瘤动物脾细胞的主要组成部分。 放射治疗，简称放疗，广泛应用于各种癌症的治疗，最近的研究表明，免疫系统在介导放疗的抗肿瘤作用中扮演
技术资料暂无技术资料 索取技术资料
IS0130 HBR东莨菪碱 神经信号通路 索莱宝
￥300
